These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 9681248

  • 1. Cytokine gene-modified tumor cells for prophylactic and therapeutic vaccination: IL-2, IFN-gamma, or combination IL-2 + IFN-gamma.
    Kircheis R, Küpcü Z, Wallner G, Wagner E.
    Cytokines Cell Mol Ther; 1998 Jun; 4(2):95-103. PubMed ID: 9681248
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-2 gene-modified allogeneic melanoma cell vaccines can induce cross-protection against syngeneic tumors in mice.
    Kircheis R, Küpcü Z, Wallner G, Rössler V, Schweighoffer T, Wagner E.
    Cancer Gene Ther; 2000 Jun; 7(6):870-8. PubMed ID: 10880017
    [Abstract] [Full Text] [Related]

  • 3. Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells.
    Abdel-Wahab Z, Dar MM, Hester D, Vervaert C, Gangavalli R, Barber J, Darrow TL, Seigler HF.
    Cell Immunol; 1996 Aug 01; 171(2):246-54. PubMed ID: 8806794
    [Abstract] [Full Text] [Related]

  • 4. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC.
    Cancer Res; 2000 Mar 15; 60(6):1663-70. PubMed ID: 10749137
    [Abstract] [Full Text] [Related]

  • 5. [Augmentation of vaccination effects of PGE2-producing tumor cells by transfection with cytokine genes].
    Ohiro Y.
    Hokkaido Igaku Zasshi; 1997 May 15; 72(3):273-84. PubMed ID: 9226467
    [Abstract] [Full Text] [Related]

  • 6. Gene-modified tumor vaccine with therapeutic potential shifts tumor-specific T cell response from a type 2 to a type 1 cytokine profile.
    Hu HM, Urba WJ, Fox BA.
    J Immunol; 1998 Sep 15; 161(6):3033-41. PubMed ID: 9743368
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
    Tanaka H, Yoshizawa H, Yamaguchi Y, Ito K, Kagamu H, Suzuki E, Gejyo F, Hamada H, Arakawa M.
    J Immunol; 1999 Mar 15; 162(6):3574-82. PubMed ID: 10092816
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide.
    Cao X, Zhang W, Wan T, Yu Y, Tao Q, Wang J.
    J Exp Clin Cancer Res; 1999 Jun 15; 18(2):173-9. PubMed ID: 10464704
    [Abstract] [Full Text] [Related]

  • 14. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
    Douin-Echinard V, Bornes S, Rochaix P, Tilkin AF, Peron JM, Bonnet J, Favre G, Couderc B.
    Cancer Gene Ther; 2000 Dec 15; 7(12):1543-56. PubMed ID: 11228533
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.
    Marchi LH, Paschoalin T, Travassos LR, Rodrigues EG.
    Cancer Gene Ther; 2011 Feb 15; 18(2):110-22. PubMed ID: 20885448
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma.
    Hillman GG, Slos P, Wang Y, Wright JL, Layer A, De Meyer M, Yudelev M, Che M, Forman JD.
    Cancer Gene Ther; 2004 Jan 15; 11(1):61-72. PubMed ID: 14681727
    [Abstract] [Full Text] [Related]

  • 19. Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study.
    Sun Y, Jurgovsky K, Möller P, Alijagic S, Dorbic T, Georgieva J, Wittig B, Schadendorf D.
    Gene Ther; 1998 Apr 15; 5(4):481-90. PubMed ID: 9614572
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.